Additionally, MDSCs are also considered tumor promoters via their immunosuppressive effect, as well as through their tumor-mediated regulation via CCL5 and CCL2 tumor-secreted molecules [20], whereas DCs constitute antigen-presenting cells (APCs), which facilitate antigen identification by CD8-positive T-cells [21]. This evidence concerns the gene CCL2 and neoplasm.